Interview with Thomas Trilling, General Manager, Basilea
You have a wide experience in the pharmaceutical industry having worked for companies such as Amgen and Servier. What attracted you to Basilea? When I first considered moving to Basilea…
Address: Scheurlstraße 21 ,D-90478 Nürnberg Postbox 440138
Tel: +49 (0) 911 946469-0
Founded in 1998 by Daniel M. Perlman, RPS implemented its business plan to build the industry’s first Pharmaceutical Resource Organization model. The RPS plan was dedicated to achieving the goal of providing the biopharmaceutical industry with an alternative to traditional outsourcing models by offering customized, integrated solutions that addressed these fundamental industry challenges.The European growth of RPS allows clients to utilize the market leading integrated clinical solutions and enhanced full-service capabilities of RPS to develop clinical products beyond the Americas and into Europe for greater value generation across a global R&D pipeline. RPS recently acquired three CROs in Europe: in Germany, France and Spain. RPS entered the German market in December 2008, when they acquired Imerem GmbH. RPS has acquired Imerem’s specialist knowledge in major indications of clinical indications: CNS (neurology and psychiatry), oncology (solid, hematological tumors), transplantation, pain, dermatology. We are highly experienced in studies with phytomedicines and complementary medicinal treatments, medicinal products, and large-scale post-marketing surveillance studies. Imerem was in particular the world-wide leading CRO in research in the “Restless Legs Syndrome.”Executive Vice President of Clinical Operations in Europe and CEO of RPS Germany is Dr. Ralf Kohnen, former founder of Imerem GmbH.
You have a wide experience in the pharmaceutical industry having worked for companies such as Amgen and Servier. What attracted you to Basilea? When I first considered moving to Basilea…
When we met Dr. Aleiotti in Italy, he said how important was Menarini´s acquisition of Berlin Chemie in the 1990s for the internationalization of the company in Eastern Europe and…
With a wide experience in other international pharmaceutical companies, what attracted you to come to Bausch&Lomb, the ophthalmology pharma company? Bausch&Lomb offered me a unique set of challenges and possibilities…
Gilead was founded in 1987 and only four years later it established itself in the German market. Since then the company has become internationally known for breakthroughs that resulted in…
As part of the PKV – the German Association of Private Health Insurance – could you briefly introduce to our readers the German private health care system and its main…
Could you briefly introduce our readers the how the GPHF managed to improve health care in developing countries since its foundation in 1987? The former abbreviation of GPHF stood for…
You have been leading GSK, one of the top five pharmaceutical companies in the German market, for just over a year, after having worked previously in Poland, the UK, France,…
See our Cookie Privacy Policy Here